|
|
|
Court ponders mass murderer Breivik's prison conditions
Legal Line News |
2017/01/18 23:59
|
An appeals court in Norway is considering whether the prison conditions under which mass murderer Anders Behring Breivik is being held amount to a violation of his human rights.
The six-day trial ended Wednesday in a makeshift courtroom inside Skien prison in southern Norway where Breivik, 37, is serving a 21-year sentence for killing 77 people in a 2011 bomb-and-shooting rampage.
Breivik's lawyer, Oystein Storrvik, spent most of the last day seeking to show that restrictions on his client's visitors and the strict control over Breivik's mail and phone calls have led to a lack of human interaction and privacy, which amounts to a violation of his rights.
The case is "really about a person that is sitting very, very alone in a small prison within a prison" since 2012, explained Storrvik.
He dismissed the benefits of the weekly visits by a state-appointed prison confidante for Breivik, saying "it's a paid job."
Addressing the court last week, Breivik said his solitary confinement had deeply damaged him and made him even more radical in his neo-Nazi beliefs.
The Norwegian state rejected the criticism and said efforts to find a prison confidante show the authorities have "gone out of their way" to remedy the situation.
In a surprise verdict last year, the Oslo District Court sided with Breivik, finding that his isolation was "inhuman (and) degrading" and breached the European Convention on Human Rights. It ordered the government to pay his legal costs.
|
|
|
|
|
|
Supreme Court pauses Alabama execution of convicted murderer
Legal Line News |
2016/12/22 00:36
|
The U.S. Supreme Court late Thursday temporarily paused Alabama's plans to execute a man convicted of killing a convenience store clerk, after defense lawyers argued that a judge unfairly imposed the death penalty after a jury recommended life in prison.
The court had narrowly ruled just a short while earlier Thursday evening that the execution could proceed, although four liberal justices said they would have halted the execution. However, the court then issued a temporary stay — its second of the evening — as attorneys for the condemned inmate quickly sought a reconsideration after that narrow decision.
While the whirlwind of judicial activity unfolded, Ronald Bert Smith Jr., 45, remained steps away from the prison chamber where he was scheduled to receive a lethal injection Thursday evening for the Nov. 8, 1994, shooting death of Huntsville store clerk Casey Wilson. It would be Alabama's second execution this year if carried out. |
|
|
|
|
|
UK Supreme Court hears landmark challenge to Brexit plans
Legal Line News |
2016/12/18 00:37
|
Britain's Supreme Court began hearing a landmark case Monday that will decide who has the power to trigger the U.K.'s exit from the European Union — the government or Parliament.
The legal battle has major constitutional implications for the balance of power between the legislature and the executive, and has inflamed Britain's already raw wound over how and whether to leave the EU.
The court's most senior justice, David Neuberger, opened the four-day hearing by condemning the "threats of serious violence and unpleasant abuse" directed at Gina Miller, one of the claimants trying to ensure Parliament gets a say.
"Threatening and abusing people because they are exercising their fundamental right to go to court undermines the rule of law," Neuberger said, banning publication of the addresses of Miller and other parties in the case.
Neuberger and 10 other justices at the country's top court must decide whether Prime Minister Theresa May's government can invoke Article 50 of the EU's key treaty, the trigger for two years of divorce talks, without the approval of lawmakers.
May plans to trigger Article 50 by the end of March, using centuries-old government powers known as royal prerogative. The powers — traditionally held by the monarch but now used by politicians — enable decisions about joining or leaving international treaties to be made without a parliamentary vote.
Financial entrepreneur Miller and another claimant, hairdresser Deir Dos Santos, went to court to argue that leaving the EU would remove some of their rights, including free movement within the bloc, and that shouldn't be done without Parliament's approval. |
|
|
|
|
|
US Supreme Court could hear Charleston company, Lexmark case
Legal Line News |
2016/12/17 00:38
|
A small Charleston company that refills and resells empty toner cartridges could soon be defending itself before the U.S. Supreme Court in a dispute that could affect huge tech companies and pharmaceutical firms.
Lexmark, a Lexington, Kentucky-based printing corporation, sued Impression Products, accusing the company of patent infringement for selling its cartridges, The Charleston Gazette-Mail reported.
At issue is what is known as the first-sale doctrine, a principle limiting a patent holder's rights after a product has been sold once.
Impression Products argued Lexmark's patents on its cartridges are no longer effective after the cartridges are sold, allowing the smaller company to sell them freely. Lexmark cartridges can cost up to hundreds of dollars, and Impression Products sells used ones at a lower price.
In February, a federal court sided with Lexmark, saying the corporation's patent rights weren't exhausted, regardless of whether the cartridges were being purchased from U.S. or foreign suppliers — Impression Products has purchased toner cartridges from Canadian suppliers in the past.
Last month, the federal government recommended the Supreme Court review the case.
Impression Products President Eric Smith explained that while this doesn't guarantee that the justices will review the case, it sharply increases the probability of it happening.
The implications of the case go beyond ink cartridges, as Samsung and Google have backed Impression Products' argument. The tech giants operate foreign supply chains that would have to jump through additional hoops if the first-sale doctrine did not apply for foreign purchases. Pharmaceutical companies such as Pfizer have supported Lexmark, with a Lexmark victory likely giving their own patents greater protection. |
|
|
|
|